スポンサーリンク
Department Of Hematology Tama Hokubu Medical Center | 論文
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
- Mechanisms of retinoid resistance in a myeloid cell line, YM711,transfected with PML/RARα cDNA : possible involvement of redox potential
- Extramedullary Blast Crisis Derived from 2 Different Clones in the Central Nervous System and Neck during Complete Cytogenetic Remission of Chronic Myelogenous Leukemia Treated with Imatinib Mesylate
- Follicular Lymphoma in Osaka, Japan : Histological Features and Chronological Change
- A Case of Hypoplastic Chronic Myelogenous Leukemia Initiating With Pancytopenia
- Potassium oxonate modulation of 5-fluororacil-induced myelotoxicity in colony forming assay of hematopoietic precursor cells.
- IMMUNOTOXIC EFFECT OF LOW DOSE CISPLATIN IN MICE
- Immunotoxicity Study of Cisplatin
- Comparative effects of three nitrosourea derivatives on cell cycle kinetics
- 13-cis Retinoic Acid Inhibits Growth of Adult T Cell Leukemia Cells and Causes Apoptosis; Possible New Indication for Retinoid Therapy
- Prognostic significance of bone marrow lymphocyte counts in the nadir phase of acute myelocytic leukemia
- Conception of Immunotherapy for Residual Leukemia Cells
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab